drugset / Trial / NCT00141258
Pregabalin Epilepsy Add-On Trial
RandomizedParallel-groupDouble-blindTreatment
Summary
To evaluate the efficacy of pregabalin as adjunctive therapy, using a flexible, optimized dose schedule with dose adjustment based on clinical response and tolerability, compared to placebo in subjects with partial seizures
Timeline
- Start
- 2005-10
- Primary completion
- —
- Completion
- 2006-08
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Pregabalin | Small molecule | — | — |